SCIOS NOVA, Inc.
42Patents
0Active
42Granted
35Portfolio score
Filing activity: Dec 16, 1985 → Feb 19, 2002
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5387742A | Transgenic mice displaying the amyloid-forming pathology of alzheimer's disease | Chemistry; Metallurgy | 198 | Expired |
| US5219739A | DNA sequences encoding bVEGF120 and hVEGF121 and methods for the production of bovine and human vascular endothelial cell growth factors, bVEGF.sub.120 and hVEGF.sub.121 | Chemistry; Metallurgy | 138 | Expired |
| US5187153A | Methods of treatment using Alzheimer's amyloid polypeptide derivatives | Physics | 91 | Expired |
| US5220013A | DNA sequence useful for the detection of Alzheimer's disease | Physics | 82 | Expired |
| US5439818A | DNA encoding human recombinant basic fibroblast growth factor | Human Necessities | 56 | Expired |
| US5221607A | Assays and reagents for amyloid deposition | Emerging Cross-Sectional Technologies | 47 | Expired |
| US5217954A | Formulations for stabilizing fibroblast growth factor | Human Necessities | 47 | Expired |
| US5322930A | Expression of recombinant polypeptides with improved purification | Chemistry; Metallurgy | 44 | Expired |
| US5212286A | Atrial Natriuretic/vasodilator peptide compounds | Chemistry; Metallurgy | 40 | Expired |
| US5449662A | Atrial natriuretic peptide clearance inhibitors which resist degradation | Human Necessities | 36 | Expired |
| US5514566A | Methods of producing recombinant fibroblast growth factors | Human Necessities | 32 | Expired |
| US5223482A | Recombinant Alzheimer's protease inhibitory amyloid protein and method of use | Emerging Cross-Sectional Technologies | 32 | Expired |
| US5811393A | Heparin binding mitogen with homology to epidermal growth factor (EGF) | Human Necessities | 24 | Expired |
| US5202239A | Expression of recombinant polypeptides with improved purification | Chemistry; Metallurgy | 22 | Expired |
| US5446020A | Method of treating diabetes with tissue-selective insulin analogs | Human Necessities | 20 | Expired |
| US6376648B2 | Protease inhibitor peptides | Chemistry; Metallurgy | 18 | Expired |
| US5250537A | 5,6,7,8,9,10-hexahydro-7 ,10-iminocyclohept[b]indole,-6,7,8,9,10-hexahydro-7,11-imino-5H-cyclooct[ b]indole and substituted derivatives | Chemistry; Metallurgy | 17 | Expired |
| US5530157A | Anti-inflammatory benzoic acid derivatives | Chemistry; Metallurgy | 16 | Expired |
| US6906033B2 | Protease inhibitor peptides | Chemistry; Metallurgy | 15 | Expired |
| US5385889A | Bradykinin antagonist peptides | Human Necessities | 12 | Expired |
| US5342764A | Recombinant expression system for human anti-inflammatory phospholipase inhibitor protein | Emerging Cross-Sectional Technologies | 8 | Expired |
| US5331095A | Process for purification of basic fibroblast growth factor | Chemistry; Metallurgy | 8 | Expired |
| US5385840A | DNA encoding analogs of human alveolar surfactant protein SP-5 | Chemistry; Metallurgy | 7 | Expired |
| US5387746A | Pulmonary hydrophobic surfactant-associated protein of 6,000 daltons molecular weight and multimers thereof | Emerging Cross-Sectional Technologies | 7 | Expired |
| US5444048A | Bradykinin antagonist pseudopeptide derivatives of olefinic aminoalkanoic acids | Human Necessities | 7 | Expired |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.